125 Co-opting IL-8 to enhance efficacy of B7H3 CAR T cells against pediatric sarcoma
Main Authors: | Laura Cobb, Jessica Lake, Kevin Winkler, Alexander Harrant, Ashley Yingst, Kristin Schaller, Eric Hoffmeyer, Madeline Larson, Dejene Tufa, Dallas Jones, Michael Verneris |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Can we persuade company car drivers to opt out?
by: Liesbeth De Wilde, et al.
Published: (2023-10-01) -
CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
by: Linchun Jin, et al.
Published: (2019-09-01) -
Inclusion of residual tissue in biobanks: opt-in or opt-out?
by: Noor A A Giesbertz, et al.
Published: (2012-01-01) -
Assessing Global Organ Donation Policies: Opt-In vs Opt-Out
by: Etheredge HR
Published: (2021-05-01) -
Harvinder opts out
by: Singh, Aftar
Published: (2014)